$CMIIU News
Last published 2mo ago
- 2mo agoCMIIUCMIICOHNIPXGColumbus Circle Capital Corp II Announces Elroy Air Was Awarded an Up to $46M Contract with U.S. ArmyGlobeNewswireSAN FRANCISCO, CA, Aug. 21, 2026 (GLOBE NEWSWIRE) -- Columbus Circle Capital Corp II (NASDAQ:CMII), a special purpose acquisition company led by the management team of Inflection Point Asset Management
- 8mo agoCMIIUColumbus Circle Capital Corp II Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing February 27, 2026GlobeNewswireNew York, NY, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Columbus Circle Capital Corp II (NASDAQ:CMIIU) (the "Company") announced today that, commencing February 27, 2026, holders of the units sold in the Company's initial
- 9mo agoCMIIUCOHNColumbus Circle Capital Corp. II and Cohen & Company Inc. Announce Completion of $230,000,000 Initial Public OfferingGlobeNewswireNew York, NY, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Columbus Circle Capital Corp. II (NASDAQ:CMIIU) (the "Company") and Cohen & Company Inc. (NYSE:COHN) ("Cohen & Company") today announced the closing of the
- 9mo agoCMIIUColumbus Circle Capital Corp II Announces Pricing of $200,000,000 Initial Public OfferingGlobeNewswireNew York, NY, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Columbus Circle Capital Corp II (NASDAQ:CMIIU) (the "Company") today announced the pricing of its initial public offering of 20,000,000 units at a price of $10.00 per
- 5y agoCMIIUSomaLogic Closes Business Combination and Will Begin Trading Under the Ticker "SLGC" on the Nasdaq Stock ExchangeGlobeNewswireSomaLogic to debut on Nasdaq as a leading publicly traded AI-data driven proteomics platform company Business combination results in approximately $630 million in gross cash proceeds to catalyze organic and inorganic growth initiatives Combined compan
- 5y agoCMIIUSomaLogic expands leadership team with new positions to drive commercial successGlobeNewswireNEW YORK and BOULDER, Colo., Aug. 31, 2021 (GLOBE NEWSWIRE) -- CM Life Sciences II (NASDAQ:CMIIU) and SomaLogic, a leader in AI data-driven proteomics technology, today announced the recent appointments of Todd Johnson as Executive Vice President of Bu
- 5y agoCMIIUSomaLogic Provides 2021 Financial Guidance Exceeding Initial Merger Combination ProjectionsGlobeNewswireNEW YORK and BOULDER, Colo., Aug. 23, 2021 (GLOBE NEWSWIRE) -- CM Life Sciences II (NASDAQ:CMIIU) and SomaLogic, Inc. ("SomaLogic" or the "Company"), a leader in AI-data driven proteomics technology, today announced that with the approach of the busine
- 5y agoCMIIUTWSTSomaLogic and Twist Bioscience Corporation announce partnership to discover novel therapeutic targets and antibodiesGlobeNewswireBOULDER, Colo. & SOUTH SAN FRANCISCO, Calif., Aug. 18, 2021 (GLOBE NEWSWIRE) -- CM Life Sciences II (NASDAQ:CMIIU) and SomaLogic, Inc., a leader in AI-data driven proteomics technology, and Twist Bioscience Corporation (NASDAQ:TWST), a company enabling
- 5y agoCMIIUSomaLogic's Melody Harris Honored with C-Suite Award by the Denver Business JournalGlobeNewswireNEW YORK and BOULDER, Colo., Aug. 12, 2021 (GLOBE NEWSWIRE) -- CM Life Sciences II (NASDAQ:CMIIU) and SomaLogic, a leader in AI data-driven proteomics technology, today announced that Melody Harris, President and Chief Operating Officer has been named
- 5y agoCMIIUSomaLogic Announces Appointment of Shaun Blakeman as Chief Financial OfficerGlobeNewswireNEW YORK and BOULDER, Colo., Aug. 02, 2021 (GLOBE NEWSWIRE) -- CM Life Sciences II (NASDAQ:CMIIU) and SomaLogic, a leader in AI-data driven proteomics technology, today announced the appointment of Shaun Blakeman as the company's Chief Financial Office
- 5y agoCMIIUSomaLogic teams with leading Boston academic center to offer the SomaScan® Platform to researchersGlobeNewswireNew York and Boulder, Colo., July 08, 2021 (GLOBE NEWSWIRE) -- CM Life Sciences II (NASDAQ:CMIIU) and SomaLogic, Inc., a leader in proteomics technology, announced today that Beth Israel Deaconess Medical Center's (BIDMC) Genomics, Proteomics, Bioinfor
- 5y agoCMIIUSomaLogic Customizable Protein Panels With Industry-Leading 7,000-Plex Assay Now AvailableBusiness WireCM Life Sciences II (NASDAQ:CMIIU) and SomaLogic, Inc., a global leader in proteomics technology, announced today that their new customizable protein panel products are now available to pharma, biotechnology and academic research customers seeking the p
- 5y agoATECCMIIUFDMTILMN+4Biotech Veterans Troy Cox, Susannah Gray and Karen McGinnis Join Biosplice Therapeutics Board of DirectorsGlobeNewswireSAN DIEGO, April 20, 2021 (GLOBE NEWSWIRE) -- Biosplice Therapeutics, Inc. ("Biosplice"), a clinical-stage biotechnology company pioneering therapeutics based on alternative pre-mRNA splicing for major diseases, announced today the addition of three in
- 5y agoCMIIUCM Life Sciences II Inc. Announces Separate Trading of its Shares of Class A Common Stock and Warrants, on or about April 15, 2021Business WireNEW YORK--(BUSINESS WIRE)--CM Life Sciences II Inc. (Nasdaq: CMIIU) (the “Company”) today announced that holders of the Company’s units sold in its initial public offering may elect to separately trade the shares of Class A common stock and redeemable warrants included in its units commencing on or about April 15, 2021.
- 5y agoCMIIUSomaLogic, Leading AI-Data Driven Proteomics Platform for Advanced Research and Clinical Applications, to Combine with CM Life Sciences II, to Drive Growth and Expand Technology PlatformBusiness WireNEW YORK & BOULDER, Colo.--(BUSINESS WIRE)--SomaLogic, a global leader in proteomics technology, powered by a proprietary platform, the largest clinical proteomic database and next generation artificial intelligence and machine learning, and CM Life Sciences II (NASDAQ: CMIIU), a special purpose acquisition company, or SPAC, sponsored by affiliates of Casdin Capital, LLC and Corvex Management LP, ...